Strategic Acquisition CoaguSense recently expanded through the acquisition of DOAC testing assets from DOASENSE GmbH, signaling growth in its point-of-care coagulation diagnostics portfolio and potential cross-sell opportunities to customers of the acquired assets.

Integrated System The Coag-Sense system offers direct clot detection and point-of-care PT/INR monitoring, presenting a compelling value proposition for clinics and hospitals seeking faster, accurate coagulation results and workflow efficiency.

Remotely Accessible With a modern tech stack and digital presence (WordPress, Google Tag Manager, JSON-LD), there are opportunities to deploy digital marketing and sales enablement tools to capture inquiries from smaller clinics and regional distributors.

Acquisition Tie‑ins As a subsidiary of i-SENS, Inc., there may be cross‑sell and channel partnerships with broader i-SENS product lines, enabling bundled offerings to larger healthcare systems and integrated diagnostics distributors.

Growth Levers Revenue range and lean headcount suggest a high‑growth, mid‑market target profile; prioritize mid-size physician offices, outpatient clinics, and durable medical equipment distributors that service anticoagulation monitoring needs.